FindTrial
Sign In

Injections, Intra-Articular

3 trials

Sponsors

Cancerology State Institute, Colima State Health Service (SSA-Colima), Mexico, Center for Research and Biological Products (CENIPBI)

Conditions

Osteoarthritis of the knee, hip, shoulder, or jaw jointsOsteoarthritis of the knee, hip, shoulder, or jaw joints Osteoarthritis of the JawTemporomandibular joint osteoarthritis

Phase 2

Bioactive formulation to treat osteoarthritis
Active, not recruitingRPCEC00000250
Cancerology State Institute, Colima State Health Service (SSA-Colima), MexicoOsteoarthritis of the knee, hip, shoulder, or jaw joints Osteoarthritis of the Jaw
Start: 2015-11-20Target: 50Updated: 2026-06-22
Ozonized platelet-rich plasma and ozonized platelet-rich fibrin in temporomandibular osteoarthritis. Fase II
Active, not recruitingRPCEC00000477
Center for Research and Biological Products (CENIPBI)Temporomandibular joint osteoarthritis
Start: 2026-05-15Target: 40Updated: 2026-06-22

Phase 3

Usual treatment plus intra-articular application of bioactive formulation for osteoarthritis
Active, not recruitingRPCEC00000277
Cancerology State Institute, Colima State Health Service (SSA-Colima), MexicoOsteoarthritis of the knee, hip, shoulder, or jaw joints
Start: 2016-03-16Target: 350Updated: 2026-06-22

Related Papers

Patient‑reported health outcomes for severe knee osteoarthritis after conservative treatment with an intra‑articular cell‑free formulation for articular cartilage regeneration combined with usual medical care vs. usual medical care alone: A randomized controlled trial
Experimental and Therapeutic Medicine2019-03-134 citations
A phase I-II controlled randomized trial using a promising novel cell-free formulation for articular cartilage regeneration as treatment of severe osteoarthritis of the knee.
2018-10-2413 citations